Hematopoietic and Lymphoid System Disorder
NCI Definition: Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. 
Hematopoietic and lymphoid system disorders most frequently harbor alterations in TP53, TET2, DNMT3A, ASXL1, and JAK2 .
TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, DNMT3A Mutation, and TET2 Mutation are the most common alterations in hematopoietic and lymphoid system disorder .
There is 1 clinical trial for hematopoietic and lymphoid system disorder, of which 1 is open and 0 are completed or closed. Of the trial that contains hematopoietic and lymphoid system disorder as an inclusion criterion, 1 is phase 2 (1 open).
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.